Next Generation BTK Inhibitors in CLL: Evolving Challenges and New Opportunities

por Frustaci, Anna Maria, Deodato, Marina, Zamprogna, Giulia, Cairoli, Roberto, Montillo, Marco, Tedeschi, Alessandra
Publicado 2023

Reply to “CLL and COVID-19 at the Hospital Clinic of Barcelona: an interim report” Analysis of six hematological centers in Lombardy: On behalf of CLL commission of Lombardy Hemato...

por Reda, Gianluigi, Noto, Alessandro, Cassin, Ramona, Zamprogna, Giulia, Borella, Chiara, Scarfò, Lydia, Farina, Lucia, Molteni, Alfredo, Ghia, Paolo, Tedeschi, Alessandra, Montillo, Marco
Publicado 2020

Identification of a Candidate Gene Set Signature for the Risk of Progression in IgM MGUS to Smoldering/Symptomatic Waldenström Macroglobulinemia (WM) by a Comparative Transcriptome...

por Trojani, Alessandra, Di Camillo, Barbara, Bossi, Luca Emanuele, Leuzzi, Livia, Greco, Antonino, Tedeschi, Alessandra, Frustaci, Anna Maria, Deodato, Marina, Zamprogna, Giulia, Beghini, Alessandro, Cairoli, Roberto
Publicado 2021

Tixagevimab/Cilgavimab Pre-exposure Prophylaxis in Patients With Lymphoproliferative Disorders on BTKi

por Zamprogna, Giulia, Frustaci, Anna Maria, Travi, Giovanna, Borella, Chiara, Reda, Gianluigi, Motta, Marina, Deodato, Marina, Bossi, Elisa, Mattiello, Veronica, Ferrari, Maria Beatrice, Cotilli, Giulia, Gambacorti-Passerini, Carlo, Cairoli, Roberto, Puoti, Massimo, Tedeschi, Alessandra
Publicado 2023

S147: EFFICACY AND SAFETY RESULTS OF MOLTO, A MULTICENTER, OPEN LABEL, PHASE II CLINICAL TRIAL EVALUATING VENETOCLAX, ATEZOLIZUMAB AND OBINUTUZUMAB COMBINATION IN RICHTER SYNDROME

por Frustaci, Anna Maria, Montillo, Marco, Rossi, Davide, Zinzani, Pier Luigi, Motta, Marina, Gaidano, Gianluca, Quaresmini, Giulia, Scarfò, Lydia, Pietrasanta, Daniela, Coscia, Marta, Deodato, Marina, Zamprogna, Giulia, Cairoli, Roberto, Stüssi, Georg, Zucca, Emanuele, Pileri, Stefano, Zenz, Thorsten, Tedeschi, Alessandra
Publicado 2023

PB1942: PARTIAL RESPONSE WITH LYMPHOCYTOSIS (PR-L) IS NOT APPLICABLE FOR ACALABRUTINIB. AN ITALIAN MULTICENTER EXPERIENCE OF REAL LIFE.

por Innocenti, Idanna, Mosca, Antonio, Tomasso, Annamaria, Galitzia, Andrea, Scarfò, Lydia, Galli, Eugenio, Laureana, Roberta, Benintende, Giulia, Mattiello, Veronica, Morelli, Francesca, Chiriu, Sabrina, Del Principe, Maria Ilaria, Zamprogna, Giulia, Gentile, Massimo, Fabbri, Nicole, Autore, Francesco, Sportoletti, Paolo, Fresa, Alberto, Catania, Gioacchino, Coscia, Marta, Tedeschi, Alessandra, Sanna, Alessandro, Varettoni, Marzia, Ghia, Paolo, Murru, Roberta, Laurenti, Luca
Publicado 2023

Efficacy of idelalisib and rituximab in relapsed/refractory chronic lymphocytic leukemia treated outside of clinical trials. A report of the Gimema Working Group

por Rigolin, Gian Matteo, Cavazzini, Francesco, Piciocchi, Alfonso, Arena, Valentina, Visentin, Andrea, Reda, Gianluigi, Zamprogna, Giulia, Cibien, Francesca, Vitagliano, Orsola, Coscia, Marta, Farina, Lucia, Gaidano, Gianluca, Murru, Roberta, Varettoni, Marzia, Paolini, Rossella, Sportoletti, Paolo, Pietrasanta, Daniela, Molinari, Anna Lia, Quaglia, Francesca M., Laurenti, Luca, Marasca, Roberto, Marchetti, Monia, Mauro, Francesca R., Crea, Enrico, Vignetti, Marco, Gentile, Massimo, Montillo, Marco, Foà, Robin, Cuneo, Antonio
Publicado 2021

Do age, fitness, and concomitant medications influence management and outcomes of patients with CLL treated with ibrutinib?

por Tedeschi, Alessandra, Frustaci, Anna Maria, Mauro, Francesca Romana, Chiarenza, Annalisa, Coscia, Marta, Ciolli, Stefania, Reda, Gianluigi, Laurenti, Luca, Varettoni, Marzia, Murru, Roberta, Baratè, Claudia, Sportoletti, Paolo, Greco, Antonino, Borella, Chiara, Rossi, Valentina, Deodato, Marina, Biagi, Annalisa, Zamprogna, Giulia, Pelle, Angelo Curto, Lapietra, Gianfranco, Vitale, Candida, Morelli, Francesca, Cassin, Ramona, Fresa, Alberto, Cavalloni, Chiara, Postorino, Massimiliano, Ielo, Claudia, Cairoli, Roberto, Di Raimondo, Francesco, Montillo, Marco, Del Poeta, Giovanni
Publicado 2021

Coexisting conditions and concomitant medications do not affect venetoclax management and survival in chronic lymphocytic leukemia

por Frustaci, Anna Maria, Del Poeta, Giovanni, Visentin, Andrea, Sportoletti, Paolo, Fresa, Alberto, Vitale, Candida, Murru, Roberta, Chiarenza, Annalisa, Sanna, Alessandro, Mauro, Francesca Romana, Reda, Gianluigi, Gentile, Massimo, Varettoni, Marzia, Baratè, Claudia, Borella, Chiara, Greco, Antonino, Deodato, Marina, Zamprogna, Giulia, Laureana, Roberta, Cipiciani, Alessandra, Galitzia, Andrea, Curto Pelle, Angelo, Morelli, Francesca, Malvisi, Lucio, Coscia, Marta, Laurenti, Luca, Trentin, Livio, Montillo, Marco, Cairoli, Roberto, Tedeschi, Alessandra
Publicado 2022